Articles tagged with Lung Cancer
A University of Florida study found that the protein Bc12 blocks DNA repair in lung cancer cells, allowing them to thrive despite damage from radiation or chemicals. The discovery provides a new understanding of how lung cancer cells evade treatments, offering potential targets for drug development.
Researchers identify hydrogen peroxide in cigarette smoke as a primary cause of lung cancer development. The study may lead to the development of 'safer' cigarettes and new treatments for lung cancer.
The National Lung Cancer Partnership has partnered with three organizations to co-sponsor new lung cancer research grants, focusing on survivorship care and nursing-sensitive patient outcomes. This move aims to address the lack of research funding for lung cancer, a leading cancer killer in the US.
Researchers at The Wistar Institute have solved the structure of p300/CBP, a gene regulator implicated in deadliest cancers. The breakthrough reveals how p300/CBP regulates a wide variety of genes and enables the development of targeted cancer therapies.
A multi-institutional study found PET more reliable than CT in characterizing lung nodules as malignant. PET's superior specificity led to correctly classifying 58% of benign nodules misclassified on CT.
A study suggests that endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and its combination with endobronchial ultrasound-guided fine-needle aspiration (EBUS-FNA) can accurately determine lung cancer stage. These minimally invasive methods show high sensitivity rates, potentially replacing traditional surgical procedures.
Researchers at Mayo Clinic have developed a new technique using two small flexible tubes to stage lung cancer, achieving a 93% accuracy rate in finding malignant lymph nodes. This method is less invasive and more precise than traditional surgical methods, allowing patients to recover the same day.
A vaccine booster has been shown to induce a persistent immune response against lung cancer, reducing the risk of recurrence. The study found that patients who received regular recall injections experienced improved immunological memory, which can be strengthened with additional vaccinations.
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that can help personalize treatment for patients with advanced non-small cell lung cancer. These biomarkers may identify patients who will respond to the Celebrex and Tarceva combination therapy, sparing them from ineffective treatments.
A $100,000 grant from Joan's Legacy will enable Cold Spring Harbor Laboratory to build upon recent lung cancer discoveries, focusing on epidermal growth factor receptors (EGFR) and their potential link to estrogen. The research aims to understand how EGFR genetic mutations contribute to non-small cell lung cancer development.
Scientists at UAB have identified a new lung cancer marker, AKR1B10, which can appear even before cancer develops. The enzyme's activity may play a role in the development of lung cancer and could be targeted by future treatments.
Researchers have identified a key gene, 14-3-3zeta, that enables lung cancer cells to survive on their own. Silencing this gene has been shown to inhibit the growth and survival of lung cancer cells, making it a potential target for selective anti-cancer drugs.
A study by Indiana University researchers found that receiving primary care during cancer treatment improves cancer survival rates, especially in lung cancer patients. Primary care utilization increased median survival rates by over fourfold, highlighting the importance of comprehensive care for whole-person health.
A new study published in PLoS Medicine found that consuming high amounts of red and processed meats increases the risk of developing bowel and lung cancer. The research, conducted by Amanda Cross and colleagues, analyzed data from a large US diet and health study involving nearly half a million men and women aged 50-71.
Researchers at M.D. Anderson Cancer Center link diet and gardening to lung cancer risk reduction, finding that smokers and nonsmokers can reduce their risk by eating four or more servings of green salad a week and working in the garden once or twice a week.
Researchers found that eating veggies, gardening, and being physically active can reduce lung cancer risk in smokers and non-smokers. Additionally, a study suggests men are more prone to developing skin cancers due to differences in antioxidant levels and DNA repair capacity.
Researchers at Duke University Medical Center have identified four blood proteins that can distinguish patients with lung cancer from those without. The blood test, which uses a classification tree to sort out likelihoods, shows promise as a less-invasive follow-up for patients with suspicious lesions.
A new study published in JCI Journal has found that CP-31398, a compound that binds to mutant forms of the p53 protein, can prevent and treat UV light–induced skin cancers in mice. The study also demonstrated that CP-31398 increased p53 function in human skin cancer cells expressing a mutant form of p53.
A five-year study will evaluate the performance of chest X-ray CAD in identifying hard-to-detect lung cancers, aiming to improve patient survival rates. The study, funded by the State of Ohio, will involve 9,000 test subjects and assess the software's ability to identify actionable pulmonary nodules.
A study by Dartmouth researchers found that rural patients are diagnosed at an earlier stage for colorectal and lung cancer compared to urban patients. The study controlled for various factors, including age, race, and education level. Rural-urban differences in cancer presentation may inform targeted screening efforts.
A comprehensive review by the UK National Health Service found that PET scans can help diagnose and treat certain types of cancer more accurately than other imaging technologies. However, it is unclear whether these advances lead to improved patient outcomes and survival rates.
Researchers found that urban colorectal and lung cancer patients present at later stages of disease than their rural counterparts. This study highlights the need for improved screening efforts in both rural and urban populations to address disparities in cancer diagnosis.
Researchers found that computer-aided detection (CAD) combined with multi-detector computed tomography (MDCT) improves radiologists' ability to detect solid lung nodules. CAD successfully matched 91.3% of nodules detected in both exams, and reduced reading time for radiologists.
The study provides a comprehensive view of the altered genetic background of lung adenocarcinoma, revealing new insights into its biology. The identification of the NKX2-1 gene highlights the importance of understanding the molecular properties of tumors to develop effective cancer diagnosis and therapy strategies.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a novel mechanism to predict survival in older women with early-stage lung cancer. Higher levels of aromatase, an enzyme that produces estrogen, are associated with more aggressive disease and lower survival rates in women over 65.
A study published in the Journal of the National Cancer Institute found that treatment with a vitamin A derivative called retinoic acid reduced the growth of lung cells in former heavy smokers. The researchers also found that the treatment slowed down cell growth in the parabasal layer of lung cells, but not in the basal layer.
A prospective study found that quality of life surpasses classic predictors like disease stage and tumor size in determining survival. Patients with better quality of life scores had a significantly higher rate of survival.
Three studies investigate how tumors respond to EGFR inhibitors, revealing the crucial role of BIM protein in triggering apoptosis. The findings suggest that induction of BIM may lead to a new way of treating tumors resistant to these drugs.
Researchers found that PET scans at 3 months post-treatment can evaluate tumor response earlier and more accurately than current methods. Stereotactic body radiotherapy may be as effective as surgery in treating small tumors, but early detection is crucial to prevent treatment delays.
A new study published in CANCER found that despite significant increases in healthcare expenditures, survival rates for elderly patients with lung cancer remained relatively stable between 1983 and 1997. The average life-expectancy rose by less than one month, while costs increased by over $20,000 per patient.
Scientists have discovered a new gene, Dmp1, linked to human lung cancer, which is often deleted in lung tumors. The study found that the non-functional Dmp1 gene leads to reduced activity of tumor suppressors p53 and Arf, allowing cancer cells to grow unchecked.
The report found that cancer death rates declined by an average of 2.1 percent per year from 2002 to 2004, nearly twice the annual decrease of 1.1 percent per year from 1993 to 2002. Cancer incidence rates among American Indians and Alaska Natives varied two-fold across six geographic regions.
Scientists identified DMP1 as a tumor suppressor that activates Arf expression, inducing p53-dependent cell cycle arrest. DMP1 deletion or haploid insufficiency accelerates lung cancer development in K-ras mutated mice and patients, suggesting its potential as a target for drug therapy.
A study published in Thorax reveals a potential early warning system for lung cancer, detecting autoantibodies in blood that are associated with solid tumours and triggered by cancerous changes. The presence of these autoantibodies in patients indicates an 80% chance of a cure if the disease has not yet spread.
Researchers at CSHL have identified three genes causing 20% of lung cancers that interact to reactivate fetal gene expression patterns leading to tumor growth. Reversing these genes may lead to new treatment options for patients.
The NIBIB Quantum Grants program funds four innovative projects to develop new technologies for metastatic lung cancer diagnosis, bio-artificial kidneys, insulin-producing cells, and nanoparticles targeting brain tumors. These advancements aim to transform healthcare with potential breakthroughs in disease treatment and prevention.
A new study led by Duke University researchers found distinct differences in tumor susceptibility to chemotherapy drugs based on gene expression profiling. This allows clinicians to predict which patients are most likely to respond to standard therapy and offers alternative options for those not responding.
A study suggests that patients with non-squamous histology achieve statistically significant higher survival when treated with ALIMTA in the second-line setting compared to those with squamous histology. The analysis also identified other predictive factors for potential benefit from treatment, including adenocarcinoma histology and go...
A new blood test has been developed to detect lung cancer in its earliest stage, promising improved diagnosis and treatment options. The test targets the Human Aspartyl (Asparaginyl) ß-Hydroxylase protein, which is abnormally expressed on the surface of cancer cells.
Researchers have identified a panel of 15 genes that can serve as a biomarker for lung cancer, which may help identify individuals at high risk for the disease. The test, which analyzed gene activity in lung cells, showed a 96% accuracy rate in identifying lung cancer patients.
A third of prostate biopsies detected cancer, with the risk increasing with each subsequent biopsy. Gene variants influencing innate immunity also linked to improved or poorer lung cancer survival in white patients. Brain tumor stem cells susceptible to a cancer-killing virus, offering new treatment hope.
Research found knee monoarthritis in 296 patients (4.4%) with rheumatic disorders, a rare condition associated with operable non-small cell lung cancer. The disease is challenging to treat unless caught early, and the discovery provides new insights into potential early warning signs.
Researchers at UT Southwestern Medical Center have found that combining radiation therapy with the drug bavituximab significantly improves the effectiveness of lung cancer treatment. The drug targets tumor blood vessels by selectively binding to exposed phospholipids, signaling white blood cells to attack and destroy them.
A common molecular pathway called retinoblastoma (RB) tumor suppressor could help predict which lung cancer patients will benefit from chemotherapy drugs. Researchers found that turning off the RB pathway resulted in an altered response to chemotherapy agents and more cancer cell death.
Researchers developed a new technique that can detect specific chromosomal damage associated with lung cancer, which may indicate an increased risk. The study found significant differences in chromosomal abnormalities between never-smokers and high-risk smokers and patients with lung cancer.
Researchers identified genes that are irreversibly activated by smoking, leading to increased lung cancer risk in former smokers. The study's findings provide insight into why former smokers remain susceptible to lung cancer despite quitting.
Researchers found that taking vitamins and minerals did not reduce liver cancer death rates in a study conducted by the National Cancer Institute. However, some vitamin-mineral combinations reduced risk in subgroups defined by age, sex, and alcohol consumption. In contrast, gene expression patterns identified 11 genes in noncancerous l...
A nationwide survey found that nearly seven in ten Americans believe the risk of dying from cancer is increasing, despite clear evidence to the contrary. The study also revealed associations between sociodemographic variables, such as gender and education level, and the likelihood of believing false statements about cancer risks.
Researchers found a strong correlation between tumor responses during treatment and three months after completion, suggesting PET scans can be performed earlier to modify treatment plans. This could lead to better tumor control and survival rates, potentially changing standard practice guidelines.
Researchers have identified IL6 as a protein that stimulates tumor growth when activated by Ras, leading to increased blood vessel formation. Suppressing IL6 activity has shown promising results in fighting tumor formation in preclinical models.
Researchers found gene variations in interleukin 1A and 1B to be a major risk factor for lung cancer, particularly among heavy smokers. These variants can lead to an overzealous inflammatory response, causing genetic damage and cancer.
A recent study found that restaurant workers exposed to tobacco smoke have higher levels of NNK, a potent lung carcinogen. The researchers concluded that clean air exemptions are unjustified and policymakers should prohibit smoking in all indoor workplaces.
Cancer researcher Dimitrios Trichopoulos received a medal of honor from the World Health Organization's cancer agency for his work linking passive smoking to lung cancer. He has also explored the Mediterranean diet's role in reducing cancer and heart disease risk.
Researchers at UT Southwestern Medical Center have discovered how the compound beta-lapachone kills certain cancer cells, leading to a new paradigm for treating non-small cell lung cancer. Beta-lapachone interacts with an enzyme called NQO1, present in high levels in non-small cell lung cancer and other solid tumors.
A study found that arsenic exposure led to a significant rise in lung and bladder cancer deaths, with mortality rates peaking 10-20 years after exposure ended. The research suggests the need for controlling arsenic concentrations in drinking water worldwide.
Death rates from lung and bladder cancer remained high decades after residents in northern Chile were exposed to high levels of arsenic, indicating a clear pattern of latency in health effects. The study found that mortality risks continued to rise long after exposure ended, supporting the need for more testing of world's water sources.
Researchers found that talc stimulates healthy cells to produce endostatin, a hormone that inhibits tumor growth and kills tumor cells. The study reveals talcum powder's potential as a therapeutic agent for metastatic lung cancer, offering new hope for patients with incurable disease.
A multi-center team has discovered a 'signature' of proteins in the blood that predicts which non-small-cell lung cancer patients will live longer when treated with targeted therapies. The findings could help physicians decide which patients to treat with drugs known as EGF receptor tyrosine kinase inhibitors.
A Phase III study suggests ALIMTA-carboplatin may deliver less toxicity than GEMZAR-carboplatin, offering comparable quality-of-life benefits and survival data. The combination also appears to benefit from a lower toxicity profile.
A large Phase III study found that shark cartilage extract AE-941 has no benefit when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer. The study did not meet its primary endpoint: survival, and the researchers cast major skepticism on the efficacy of shark cartilage products.